1. Khan KS, Wojdyla D, Say L. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367: 1066 – 1074.
2. Bręborowicz GH, Sobieszczyk S, Słomko Z. Krwotoki w drugiej połowie ciąży. W: Bręborowicz GH, (red.) Ciąża wysokiego ryzyka. Poznań, OWN 2010, 241-258.
3. Clark SL. Placenta previa and abruptio placentae. W: Creasy RK, Resnik R, (red.) Maternalfetal medicine: Principles and Practice. 4th Ed, Philadelphia, WB Saunders, 1999, 621-631.
4. Bauer S, Bonanno C. Abnormal placentation. Semin Perinatol. 2009, 33: 88-96.
5. Levine D, Levy R. Epidemiology of bleeding and hemorrhage. W: Blickstein I, Keith LG, (red.) Multiple Pregnancy. Epidemiology, Gestation and Perinatal outcome. Oxon, Taylor&Francis 2005, 692-697.
6. Chattopadhyay SK, Kharif H, Sherbeeni MM. Placenta praevia and accreta after previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 1993, 52(3):151-156.
7. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol. 1985, 66(1):89-92.
8. Lavery JP. Placenta previa. Clin Obstet Gynecol. 1990. 33: 414.
9. Laurie MR, et al. The use of second-trimester transvaginal sonography to predict placenta previa. Ultrasound Obstet Gynecol. 1996, 8:337-340.
10. Oppenheimer L, Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007, 29(3): 261-273.
11. Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med. 2002, 21: 837-840.
12. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. [red.] Disorders of placental development. [W]: Placental pathology. Atlas of nontumor pathology. The American registry of pathology. Washington DC, 2004, 47-74.
13. Nyberg DA, Cyr DR, Mack LA, Wilson DA, Shuman WP. Sonographic spectrum of placental abruption. Am. J. Roentgenol. 1987, 148: 161-164.
14. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Pre-pregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand. 2006; 85: 40-44.
15. Ball RH, Ade CM, Schoenborn JA, Crane JP. The clinical significance of ultransonographically detected subchorionic hemorrhages. Am J Obstet Gynecol. 1996, 174: 996-1002.
16. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol. 2001, 153: 332-337.
17. Khong TY, Robertson WB. Placenta acreta and placenta praevia acreta. Placenta. 1987, 8: 399-409.
18. Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998; 53(8):509–517.
19. Palacios-Jaraquemada JM. Diagnosis and management of placenta accreta. Best Pract Res Clin Obstet Gynaecol. 2008, 22(6):1133-1148.
20. Esakoff TF, Sparks TN, Kaimal AJ, Kim LH, Feldstein VA, Goldstein RB. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet Gynecol. 2011; 37(3):324–327.
21. Oyelese Y, Canterino JC. Placenta previa and placenta accreta. W: Sheiner E. (red.) Bleeding during pregnancy. Springer, 2011, 135-150.
22. Roethlisberger M, Womastek I, Posch M, Husslein P, Pateisky N, Lehner R. Early postpartum hysterectomy: incidence and risk factors. Acta Obstet Gynecol Scand. 2010; 89(8):1040–1044.
23. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accrete. Am J Obstet Gynecol. 1997, 177(1): 210-214.
24. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accrete – summary of 10 years: a survey of 310 cases. Placenta. 2002, 23: 210-214.
25. Fox H. Placenta accrete, 1945 – 1969. Obstet Gynecol Surv. 1972, 27:475-490.
26. Morison JE. Placenta accreta: a clinicopathologic review of 67 cases. [W]: Wynn R, (red.) Volume 7: obstetrics and gynecology annual. New York, Appleton-Century-Crofts, 1978, 107-123.
27. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, Moore TR, Resnik R. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010, 115(1):65-69.
28. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006, 107(4):927-941.
29. Ghourab S. Third-trimester transvaginal ultrasonography in placenta previa: does the shape of the lower placental edge predict clinical outcome? Ultrasound Obstet Gynecol. 2001, 18(2):103-108.
30. Henrich W, Fuchs I, Ehrenstein T, Kjos S, Schmider A, Dudenhausen JW. Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in woman infected with HIV. Ultrasound Obstet Gynecol. 2002, 20: 90-93.
31. Parva M, Chamchad D, Keegan J, Gerson A, Horrow J. Placenta percreta with invasion of the bladder wall: management with multi-disciplinary approach. J Clin Anesth. 2010, 22:209-212.
32. Woodring TC, Klauser CK, Bofill JA, Martin RW, Morrison JC. Prediction of placenta accreta by ultrasonography and color Doppler imaging. J Matern Fetal Neonatal Med. 2011, 24(1): 118-121.
33. Bręborowicz GH, Markwitz W, Ropacka-Lesiak M, Gaca M, Nowakowski P, Gruca-Stryjak K, Kruszyński G. Zachowawcze postępowanie w placenta previa percreta przerastającym ściany pęcherza moczowego. Ginekol Pol. 2010, 81(11):865-869.
34. Lerner JP, Deane S, Timor-Tritsch IE. Characterization of placenta accreta using transvaginal sonography and color Doppler imaging. Ultrasound Obstet Gynecol. 1995, 5(3):198-201.
35. Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med. 1992, 11(7):333-343.
36. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol. 2000, 15(1):28-35.
37. Twickler DM, Lucas MJ, Balis AB, Santos-Ramos R, Martin L, Malone S, Rogers B. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med. 2000, 9(6):330-335.
38. Comstock CH, Love Jr JJ, Bronsteen RA, Lee W, Vettraino IM, Huang RR. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004; 190(4):1135–1140.
39. Sonin A. Nonoperative Treatment of Placenta Percreta: Value of MR Imaging. AJR. 2001, 177:1301-1303.
40. Conrad JA, Lee DK, Chaljub G, Ernst RD, Adegbovega P, Gei AF, Walser EM. Placenta percreta: magnetic resonance imaging and temporary bilateral internal iliac artery balloon occlusion. J Womens Imaging. 2002, 4(3):139-144.
41. Heiskanen N, Kröger J, Kainulainen S, Heinonen S. Placenta percreta: methotrexate treatment and MRI findings. Am J Perinatol. 2008, 25(2):91-92.
42. Bakri YN, Rifai A, Legarth J. Placenta previa-percreta: magnetic resonance imaging findings and methotrexate therapy after hysterectomy. Am J Obstet Gynecol. 1993 Jul;169(1):213-4.
43. El-Bialy G, Kassab A, Armstrong M. Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta. Arch Gynecol Obstet. 2007, 276(4):371-373.
44. Lax A, Prince MR, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging. 2007, 25(1):87-93.
45. Thorp JM Jr, Councell RB, Sandridge DA, Wiest HH. Antepartum diagnosis of placenta previa percreta by magnetic resonance imaging. Obstet Gynecol. 1992, 80:506-508.
46. Maldjian C, Adam R, Pelosi M, Pelosi M 3rd, Rudelli RD, Maldjian J. MRI appearance of placenta percreta and placenta accreta. Magn Reson Imaging. 1999, 17(7):965-971.
47. Lam G, Kuller J, McMahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investig. 2002, 9(1):37-40.
48. Chan BCP, Lam HSW, Yuen JHF, Lam TPW, Tso WK, Pun TC, Lee CP. Conservative management of placenta praevia with accrete. Hong Kong Med J 2008, 14:479-484.
49. Konijeti R, Rajfer J, Askari A. Placenta percreta and the urologist. Rev Urol. 2009, 11(3):173-176.
50. Silver LE, Hobel CJ, Lagasse L, Luttrull JW, Platt LD. Placenta previa percreta with bladder involvement: new considerations and review of the literature. Ultrasound Obstet Gynecol. 1997, 9(2):131-138.
51. Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta pervia. Am J Obstet Gynecol. 1980, 137: 687-695.
52. McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol. 1985, 65: 176-182.
53. Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, Silver RM. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011, 117:331-337.
54. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996, 175: 1632-1638.
55. Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010, 116(4):835-842.
56. Hong TM, Tseng HS, Lee RC, Wang JH, Chang CY. Uterine artery embolization: an effective treatment for intractable obstetric haemorrhage. Clin Radiol. 2004, 59(1):96-101.
57. Sumigama S, Itakura A, Ota T, Okada M, Kotani T, Hayakawa H, Yoshida K, Ishikawa K, Hayashi K, Kurauchi O, Yamada S, Nakamura H, Matsusawa K, Sakakibara K, Ito M, Kawai M, Kikkawa F. Placenta previa increta/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course. J Obstet Gynaecol Res. 2007, 33(5):606-611.
58. Wells I. Internal iliac artery embolization in the management of pelvic bleeding. Clin Radiol. 1996, 51(12):825-827.
59. Henrich W, Surbek D, Kainer F, Grottke O, Hopp H, Kiesewetter H, Koscielny J, Maul H, Schlembach D, von Tempelhoff GF, Rath W. Diagnosis and treatment of peripartum bleeding. J Perinat Med. 2008, 36(6):467-478.
60. Lee PS, Bakelaar R, Fitpatrick CB, Ellestad SC, Havrilesky LJ, Alvarez Secord A. Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol. 2008, 112:421-424.
61. Endo T, Hayashi T, Shimizu A, Matsuura M, Mizuuchi M, Nagasawa K, Ezaka Y, Baba T, Ishioka S, Saito T. Successful uterus-preserving surgery for treatment of chemotherapy-resistant placenta increta. Gynecol Obstet Invest. 2010, 69(2):112-115.
62. Scarantino SE, Reilly JG, Moretti ML, Pillari VT. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol. 1999, 94:825-827.
63. Karam AK, Bristow RE, Bienstock J, Montz FJ. Argon beam coagulation facilitates management of placenta percreta with bladder invasion. Obstet Gynecol. 2003, 102:555-556.
64. Schnorr JA, Singer JS, Udoff EJ, Taylor PT. Late uterine wedge resection of placenta increta. Obstet Gynecol. 1999, 94:823-825.
65. Chou MM, Hwang JI, Tseng JJ, Ho ES. Internal iliac artery embolization before hysterectomy for placenta accrete. J Vasc Interv Radiol. 2003, 14: 1195-1199.
66. Mitty HA, Sterling KM, Alvarez M, Gendler R. Obstetric hemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology. 1993, 188(1):183-187.
67. Yi KW, Oh MJ, Seo TS, So KA, Paek YC, Kim HJ. Prophylactic hypogastric artery ballooning in a patient with complete placenta previa and increta. J Korean Med Sci. 2010, 25(4):651-655.
68. Jaffe R, DuBeshter B, Sherer DM, Thompson EA, Woods JR Jr. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol. 1994, 171(2):558-559.
69. Sherer DM, Gorelick C, Zigalo A, Sclafani S, Zinn HL, Abulafia O.
Placenta previa percreta managed conservatively with methotrexate and multiple bilateral uterine artery embolizations. Ultrasound Obstet Gynecol. 2007,30(2):227-228.
70. Hatfield JL, Brumsted JR, Cooper BC. Conservative treatment of placenta accreta. J Minim Invasive Gynecol. 2006, 13(6):510-513.
71. Sentilhes L, Kayem G, Ambroselli C, Provansal M, Fernandez H, Perrotin F, Winer N, Pierre F, Benachi A, Dreyfus M, Bauville E, Mahieu-Caputo D, Marpeau L, Descamps P, Bretelle F, Goffinet F. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010, 25(11):2803-2810.
72. Bręborowicz GH, Markwitz W, Gaca M, Koziołek A, Ropacka-Lesiak M, Dera A, Brych M, Szymankiewicz-Bręborowicz M, Kruszyński G, Gruca-Stryjak K, Madejczyk M, Szpera-Goździewicz A, Krzyścin M. Conservative management of placenta previa complicated by abnormal placentation. J Matern Fetal Neonatal Med. 2013, Mar 25.
73. Lam H, Pun TC, Lam PW. Successful conservative management of placenta previa accreta during cesarean section. Int J Gynaecol Obstet. 2004, 86(1):31-32.
74. Kazandi M. Conservative and surgical treatment of abnormal placentation: report of five cases and review of the literature. Clin Exp Obstet Gynecol. 2010, 37(4):310-312.
75. Adair SR, Elamin D, Tharmaratnam S. Placenta increta; conservative management -- a successful outcome. Case report and literature review. J Matern Fetal Neonatal Med. 2004, 15(4):275-278.
76. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA. Placenta accreta and methotrexate therapy: three case reports. J Perinatol. 2000, 20(5):331-334.
77. Wehrum MJ, Buhimschi IA, Salafia C, Thung S, Bahtiyar MO, Werner EF, Campbell KH, Laky C, Sfakianaki AK, Zhao G, Funai EF, Buhimschi CS. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol. 2011, 204(5):411.e1-411.e11.
78. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011, 90(10):1140-1146.
79. Cheung CS, Chan BC. The sonographic appearance and obstetric management of placenta accreta. Int J Womens Health. 2012; 4: 587–594.
80. Yang JI, Lim YK, Kim HS, Chang KH, Lee JP, Ryu HS. Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior cesarean section. Ultrasound Obstet Gynecol. 2006, 28(2):178-182.
81. Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand. 2005, 84(8):716-724.
82. McLean LA, Heilbrun ME, Eller AG, Kennedy AM, Woodward PJ. Assessing the role of magnetic resonance imaging in the management of gravid patients at risk for placenta accreta. Acad Radiol. 2011, 18(9):1175-1180.
83. Hayes E, Ayida G, Crocker A. The morbidly adherent placenta: diagnosis and management options. Curr Opin Obstet Gynecol. 2011;23(6):448–453.
84. Teo SB, Kanagalingam D, Tan HK, Tan LK. Massive postpartum haemorrhage after uterus-conserving surgery in placenta percreta: the danger of the partial placenta percreta. BJOG. 2008, 115(6):789-792.
85. Alanis M, Hurst BS, Marshburn PB, Matthews ML. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril. 2006, 86(5):1514.e.3-7.
86. Bishop S, Butler K, Monaghan S, Chan K, Murphy G, Edozien L. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth. 2011, 20:70-73.
87. Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M; U.K. Obstetric Surveillance System (UKOSS). Uterine compression sutures for the management of severe postpartum hemorrhage. Obstet Gynecol. 2011, 117(1):14-20.
88. Johanson R, Kumar M, Obhrai M, Young P. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG. 2001, 108(4):420-422.
89. Albayrak M, Ozdemir I, Koc O, Demiraran Y. Post-partum haemorrhage from the lower uterine segment secondary to placenta praevia/accreta: successful conservative management with Foley balloon tamponade. Aust N Z J Obstet Gynaecol. 2011, 51(4):377-380.
90. Ge J, Liao H, Duan L, Wei Q, Zeng W. Uterine packing during cesarean section in the management of intractable hemorrhage in central placenta previa. Arch Gynecol Obstet. 2012, 285(2):285-289.
91. Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M. Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG. 2011, 118(7):856-864.
92. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol. 1994, 171(3):694-700.
93. Evsen MS, Sak ME, Soydine HE, Basaranoglu S, Bakir C, Sak S, Gul T. Internal iliac artery ligation for severe postpartum hemorrhage. Ginekol Pol. 2012, 83(9):665-668.
94. Evsen MS, Sak ME, Soydine HE, Nur CF, Mehmet O, Gul T. Retrospective analysis of placenta accreta: management strategies--evaluation of 41 cases. Ginekol Pol. 2012, 83(7):501-504.
95. Wong VV, Burke G. Planned conservative management of placenta percreta. J Obstet Gynaecol. 2012, 32(5):447-452.
96. Kayem G, Pannier E, Goffinet F, Grangé G, Cabrol D. Fertility after conservative treatment of placenta accreta. Fertil Steril. 2002, 78(3):637-638.
97. Tikkanen M, Stefanovic V, Paavonen J. Placenta previa percreta left in situ - management by delayed hysterectomy: a case report. J Med Case Rep. 2011, 5:418.
98. Meyer NP, Ward GH, Chandraharan E. Conservative approach to the management of morbidly adherent placentae. Ceylon Med J. 2012, 57(1):36-39.
99. Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004, 104(3):531-536.
100. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, Winer N, Pierre F, Benachi A, Dreyfus M, Bauville E, Mahieu-Caputo D, Marpeau L, Descamps P,
Goffinet F, Bretelle F. Maternal outcome after conservative treatment of placenta accrete. Obstet Gynecol. 2010, 115(3):526-534.
101. Bouvier A, Sentilhes L, Thouveny F, Bouet PE, Gillard P, Willoteaux S, Aubé C. Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. Clin Radiol. 2012, 67(11):1089-1094.
102. Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accreta. Obstet Gynecol. 1999, 93(4):545-550.
103. Honig A, Rieger L, Thanner F, Eck M, Sutterlin M, Dietl J. Placenta percreta with subsequent uterine rupture at 15 weeks of gestation after two previous cesarean sections. J Obstet Gynaecol Res. 2005, 31(5):439-443.
104. Fleisch MC, Lux J, Schoppe M, Grieshaber K, Hampl M. Placenta percreta leading to spontaneous complete uterine rupture in the second trimester. Example of a fatal complication of abnormal placentation following uterine scarring. Gynecol Obstet Invest. 2008, 65(2):81-83.
105. Höpker M, Fleckenstein G, Heyl W, Sattler B, Emons G. Placenta percreta in week 10 of pregnancy with consecutive hysterectomy: case report. Hum Reprod. 2002, 17(3):817-820
106. Woźniak S, Kłudka-Sternik M, Czuczwar P, Szkodziak P, Paszkowski M, Paszkowski T. Placenta percreta leading to uterine rupture at 18 weeks of pregnancy with consecutive hysterectomy: a case report. Ginekol Pol. 2013, 84: 318-320.
107. Wong TY. Emergency peripartum hysterectomy: a 10-year review in a tertiary obstetric hospital. N Z Med J. 2011, 124:34-39.
108. Dinkel HP, Dürig P, Schnatterbeck P, Triller J. Percutaneous treatment of placenta percreta using coil embolization. J Endovasc Ther. 2003, 10(1):158-162.
109. Meyer NP, Ward GH, Chandraharan E. Conservative approach to the management of morbidly adherent placentae. Ceylon Med J. 2012, 57:36-39.
110. Matsubara S. Bladder-opening technique for hysterectomy for placenta previa percreta. Arch Gynecol Obstet. 2011, 283(6):1427-1428.
111. Sijanović S, Rubin M, Topolovec Z, Vidosavljević D, Sijanović I. Placenta previa percreta with bladder invasion. Med Glas (Zenica). 2011, 8(1):66-68.
112. Abbas F, Talati J, Wasti S, Akram S, Ghaffar S, Qureshi R. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. J Urol. 2000, 164:1270-1274.